• Home
  • News
  • Calendar
  • About DF/HCC
  • Membership
  • Visitor Center


    DF/HCC Member Awarded Fellow of American Society of Clinical Oncology (FASCO) Award




    Stephen A
    Taking Cabazitaxel into Childhood Cancers

    Taxol (paclitaxel) and related taxane drugs are widely used chemotherapies against solid tumor types in adults

    Afatinib with Post-Operative Radiation in Head and Neck Cancer
    Visualizing the Birth of Cancer in Zebrafish

    Cancer behaves differently in living animals than it does in a dish, so designing animal models is integral to both basic and clinical research in the DF/HCC Cancer Genetics Program

    Cancer Genetics Broadens Its Quest

    A revolution in cancer began almost 50 years ago when Dana-Farber researcher Frederick Li, MD, proposed that genes can raise the risk of inheriting cancer

    Combining PI3K and PARP Inhibition in Breast and Ovarian Cancers

    Of the 180,000 new breast cancers diagnosed yearly in the US, about 20 percent are triple negative breast cancers (TBNC), lacking the HER2 receptor, as well as ligands (binding places) for estrogen and progesterone

    Inhibiting EGFR in Glioblastoma

    Glioblastomas are the most aggressive primary brain tumors in adults, with a median survival of only 9 to 15 months

Displaying results 22 to 28 out of 206